The team that brought you Karuna – recently sold to Bristol-Myers Squibb for $14 billion – has set up a neuropsychiatry-focused biotech called Seaport Therapeutics. Karuna co-founder Daphne ...

Karuna Therapeutics has unveiled positive topline results from its phase 3 EMERGENT-2 trial evaluating the efficacy, safety, and tolerability of its lead investigational therapy, KarXT (xanomeline ...

Karuna is a correspondent at Business Insider India, where she writes about the many manifestations of the internet. She takes a closer look at how our daily lives are affected and shaped by the ...

A key activist of the Karuna group has reportedly decamped and fled to India while Karuna loyalists are alleged to be holding a newspaper editor and journalists hostage to force them to publish ...